Skip to main content
BeyondSpring Inc. logo

BeyondSpring Inc. — Investor Relations & Filings

Ticker · BYSI ISIN · KYG108301006 US Manufacturing
Open in API
Filings indexed 234 across all filing types
Latest filing 2026-06-04 Board/Management Inform…
Country US United States of America
Listing US BYSI

About BeyondSpring Inc.

https://www.beyondspringpharma.com/en/

BeyondSpring Inc. is a clinical-stage biopharmaceutical company that develops innovative immuno-oncology cancer therapies. The company's primary focus is on addressing unmet medical needs and improving clinical outcomes for cancer patients. Its pipeline includes a lead asset, Plinabulin, which is a first-in-class small molecule agent. Additionally, the company operates a Targeted Protein Degradation (TPD) platform to advance other potential treatments. BeyondSpring is committed to developing novel cancer therapies to enhance the standard of care in oncology.

Recent filings

Filing Released Lang Actions
FORM 8-K
Board/Management Information Classification · 92% confidence The document is a U.S. SEC Form 8-K current report dated June 4, 2026. The primary content under Item 5.02 describes the departure of the CEO, election/appointment of a new CEO and CFO, and appointment of a Vice Chair of the Board—i.e., changes in senior management and board positions. There is no substantive financial data, earnings figures, or regulatory/legal action; it is an announcement of board and officer changes. This corresponds to the Board/Management Information category (MANG).
2026-06-04 English
8-K - BeyondSpring Inc. (0001677940) (Filer)
Earnings Release Classification · 80% confidence The document is a SEC Form 8-K “Current Report” dated May 13, 2026, under Item 2.02 “Results of Operations and Financial Condition,” which furnishes a press release announcing the quarter ended March 31, 2026 financial results as Exhibit 99.1. This is the initial earnings announcement for the quarter, matching the definition of an Earnings Release. Q1 2026
2026-05-13 English
8-K - BeyondSpring Inc. (0001677940) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 25, 2026, reporting the issuance of a press release announcing financial results for the full year ended December 31, 2025. The text explicitly states that the press release is furnished as an exhibit and incorporated by reference, and the Form 8-K itself does not contain the financial results but only announces them. The document length is 3850 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document that announces the release of a financial report but does not contain the report itself should be classified as a Regulatory Filing (RNS), as it does not contain substantive financial data or the full report itself.
2026-03-25 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by BeyondSpring Inc. It details an update on a Preferred Share Purchase Agreement and related transactions, including the timing and conditions of share purchases. The document does not contain financial statements or detailed financial analysis but rather provides an update on financing-related agreements and transactions. It is not an annual or quarterly report, audit report, earnings release, or any other detailed financial report. The content fits the category of Capital/Financing Update, as it discusses financing activities and capital structure changes. The document length is 6716 characters, which is sufficient to provide substantive information rather than a mere announcement. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-12-15 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement involving the issuance and sale of shares, including details about the securities purchase agreement and the transaction closing. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is primarily an announcement of a financing transaction and related agreements. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 5498 characters, which is sufficient to contain substantive information about the transaction rather than just a brief announcement or a report publication notice.
2025-11-21 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.